Pharosyn Raises €2.5M Seed

Pharosyn, a London-based startup building AI infrastructure for commercial decision-making in the pharmaceutical sector, has successfully raised €2.5 million in a new funding round. The investment will be used to expand the reach of its platform and support wider adoption among pharmaceutical commercial and portfolio strategy teams.

Investors

The round was led by Moonfire, with additional participation from Entrepreneurs First, Transpose Platform, and General Advance.

Pharosyn Use of Funds

Pharosyn plans to utilize the newly raised capital to scale its product and drive deeper integration across pharmaceutical commercial and portfolio strategy teams. The company aims to enhance its AI infrastructure to provide improved depth of insight, scope of analysis, and operational speed for strategic decision-making.

About Pharosyn

Founded in 2025 by Stephen Cowley and Joshua Hampson, Pharosyn is an AI-powered competitive intelligence platform specifically designed for the biopharma industry. The company monitors clinical, regulatory, and commercial data to generate customized strategic reports. Its technology is designed to assist senior directors at major pharmaceutical firms in resource allocation and strategic planning.

Funding Details

Company Website: https://pharosyn.info

Company: Pharosyn
Raised: €2.5M
Funding Date: September 2, 2026
Lead Investor: Moonfire
Additional Investors: Entrepreneurs First, Transpose Platform, General Advance
Software Category: PharmaTech
Source: https://www.eu-startups.com/2026/09/uk-startup-pharosyn-raises-e2-5-million-for-pharma-competitive-intelligence-platform/